| Literature DB >> 34876228 |
Jitsupa Nithiuthai1, Arunotai Siriussawakul1,2, Rangsinee Junkai1, Nutthakorn Horugsa1, Sunit Jarungjitaree2, Namtip Triyasunant3.
Abstract
BACKGROUND: The incidence of postoperative pulmonary complications (PPCs) is increasing in line with the rise in the number of surgical procedures performed on geriatric patients. In this study, we determined the incidence and risk factors of PPCs in elderly Thai patients who underwent upper abdominal procedures, and we investigated whether the Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) score helps to predict PPCs in Thais.Entities:
Keywords: ARISCAT; Abdominal surgery; Ageing; Elderly; Postoperative; Pulmonary complications; Thai
Year: 2021 PMID: 34876228 PMCID: PMC8653534 DOI: 10.1186/s13741-021-00214-3
Source DB: PubMed Journal: Perioper Med (Lond) ISSN: 2047-0525
Fig. 1Participant recruitment
Patient demographic data
| Demographic data | PPCs ( | No PPCs ( | |
|---|---|---|---|
| Age (years) | 75.0 ± 7.7 | 73.5 ± 6.5 | 0.052 |
| Male sex | 46 (54.1%) | 488 (48.1%) | 0.285 |
| ASA classification > 2 | 50 (58.8%) | 452 (44.5%) | 0.011 |
| BMI (kg/m2) | 23.7 ± 4.2 | 24.1 ± 4.2 | 0.389 |
| Previous pulmonary disease | 4 (4.7%) | 31 (3.1%) | 0.340 |
| Respiratory infection in preceding month | 0 | 7 (0.7%) | 1.000 |
| History of smoking | 27 (31.8%) | 229 (22.6%) | 0.054 |
| Current smoker | 7 (8.2%) | 38 (3.7%) | 0.077 |
| Chronic obstructive pulmonary disease | 3 (3.5%) | 22 (2.2%) | 0.434 |
| Asthma | 2 (2.4%) | 23 (2.3%) | 1.000 |
| Obstructive sleep apnea | 2 (2.4%) | 14 (1.4%) | 0.354 |
| Congestive heart failure | 1 (1.2%) | 2 (0.2%) | 0.215 |
| Preoperative SpO2 (%) | 97.8 ± 1.5 | 98.3 ± 1.7 | 0.012 |
| Preoperative albumin (g/dL) | 3.4 ± 1.0 | 3.80 ± 1.2 | 0.002 |
| Preoperative Hb (g/dL) | 11.0 ± 2.3 | 11.9 ± 2.0 | < 0.001 |
| Preoperative HCO3 | 25.0 ± 3.5 | 25.8 ± 2.8 | 0.053 |
| Preoperative creatinine | 1.3 ± 1.5 | 1.1 ± 0.8 | 0.224 |
| Abnormal CXR | 24 (28.2%) | 252 (24.8%) | 0.486 |
| Spirometer usage | 5 (5.9%) | 51 (5.0%) | 0.598 |
| Deep-breathing exercises | 2 (2.4%) | 23 (2.3%) | 0.707 |
Data presented as n (%) or mean ± SD
Abbreviations: ASA American Society for Anesthesiologists physical status, BMI body mass index, CXR chest X-ray, Hb hemoglobin, HCO bicarbonate, SpO peripheral capillary oxygen saturation/pulse oximetry
Intraoperative parameters
| Intraoperative parameters | PPCs ( | No PPCs ( | |
|---|---|---|---|
| Open surgery | 60 (70.6%) | 450 (44.3%) | < 0.001 |
| Emergency surgery | 14 (16.5%) | 52 (5.1%) | < 0.001 |
| Duration of surgery | 3.1 (1.8, 5.0) | 1.8 (1.2, 3.2) | < 0.001 |
| Anesthesia technique | 0.012 | ||
| GA | 51 (60%) | 739 (72.8%) | |
| Combined GA & epidural | 34 (40%) | 276 (27.2%) | |
| Crystalloid IV (mL) | 1550 (1000, 2800) | 700 (400, 1700) | < 0.001 |
| Blood loss (mL) | 350 (150, 1000) | 50 (10. 300) | < 0.001 |
| Inhalation | 0.147 | ||
| Isoflurane | 4 (4.70%) | 70 (6.9%) | |
| Sevoflurane | 21 (24.7%) | 335 (33%) | |
| Desflurane | 60 (70.6%) | 603 (59.4%) | |
| Midazolam used | 20 (23.5%) | 162 (16.0%) | 0.071 |
| Neuromuscular blocking | 0.005 | ||
| Cisatracurium | 49 (57.6%) | 605(59.6%) | 0.724 |
| Atracurium | 22 (25.9%) | 348(34.3%) | 0.115 |
| Rocuronium | 14 (16.5%) | 59(5.8%) | < 0.001 |
| Ventilator setting | 0.608 | ||
| VCV mode | 63 (74.1% | 643 (63.3%) | |
| PCV mode | 18 (21.2%) | 159 (15.7%) | |
| TV (cc/kg) | 8.9 ± 1.2 | 9.0 ± 1.4 | 0.459 |
| PAP (cmH2O) | 20.7 ± 5.3 | 21.2 ± 4.5 | 0.346 |
| RR (min) | 12.2 ± 2.2 | 12.4 ± 2.7 | 0.400 |
| PEEP (cm·H2O) | 4.8 ± 0.83 | 4.8 ± 0.9 | 0.994 |
| ARISCAT score | 41 (34–52) | 32 (18–41) | < 0.001 |
Data presented as n (%), mean ± SD, or median (IQR)
Abbreviations: ARISCAT Assess Respiratory Risk in Surgical Patients in Catalonia, GA general anesthesia, IV intravenous, PAP peak airway pressure, PCV pressure-controlled ventilation, PEEP positive end-expiratory pressure, RR respiratory rate, TV tidal volume, VCV volume-controlled ventilation
Postoperative parameters
| Postoperative parameters | PPCs ( | No PPCs ( | |
|---|---|---|---|
| Postoperative ventilator (h) | 73 (32.5, 270) | 20 (16, 81.25) | 0.029 |
| Numerical pain rating score | 5.9 ± 3.2 | 5.3 ± 3.2 | 0.074 |
| Morphine dose (mg) | 6.4 ± 5.6 | 5.4 ± 3.2 | 0.647 |
| Pethidine dose (mg) | 45.0 ± 7.1 | 42.6 ± 12.2 | 0.823 |
| Fentanyl dose (mcg) | 103.3 ± 52.5 | 91.8 ± 41.1 | 0.145 |
| Length of hospital stay (days) | 16 (9, 37.5) | 5 (3, 9) | < 0.001 |
| Length of ICU stay (days) | 4 (3, 10) | 1 (1, 4) | 0.032 |
Data presented as mean ± SD
Abbreviation: ICU intensive care unit
Results of multivariate regression analysis
| Protective/risk factors | Adjusted OR | 95% CI | |
|---|---|---|---|
| ASA classification > 2 | 1.30 | 0.80–2.09 | 0.290 |
| Preoperative SpO2 ≤ 95% | 2.60 | 1.23–5.51 | 0.012 |
| Preop. Hb < 10 mg/dL | 1.24 | 0.69–2.21 | 0.479 |
| Preoperative albumin < 3.5 g/dL | 1.70 | 1.02–2.83 | 0.040 |
| Duration of surgery (reference < 2 h) | 1 | ||
| 2–3 h | 1.05 | 0.50–2.21 | 0.900 |
| > 3 h | 2.05 | 1.00–4.22 | 0.050 |
| Open surgery | 1.49 | 0.83–2.67 | 0.187 |
| Emergency surgery | 2.84 | 1.39–5.83 | 0.004 |
| Crystalloid IV > 1000 mL | 1.88 | 0.89–4.00 | 0.100 |
Abbreviations: 95% CI 95% confidence interval, ASA American Society for Anesthesiologists physical status, Hb hemoglobin, IV intravenous, OR odds ratio, SpO peripheral capillary oxygen saturation/pulse oximetry
Major and minor surgery subgroup analysis
| Factors | Major surgery ( | Minor surgery ( | ||||
|---|---|---|---|---|---|---|
| PPCs ( | No PPCs ( | PPCs ( | No PPCs ( | |||
| Duration of surgery | 0.034 | 0.018 | ||||
| < 2 h | 10 (7.9%) | 116 (92.1%) | 14 (3.1%) | 432 (96.9%) | ||
| 2–3 h | 9 (7.3%) | 115 (92.7%) | 7 (7.4%) | 88 (92.6%) | ||
| > 3 h | 42 (14.7%) | 243 (85.3%) | 3 (12.5%) | 21 (87.5%) | ||
| Neuromuscular blocking | 0.005 | 0.059 | ||||
| Rocuronium | 10 (27.0%) | 27 (73.0%) | 4 (11.1%) | 32 (88.9%) | ||
| Others | 51 (10.2%) | 447 (89.8%) | 20 (3.8%) | 509 (96.2%) | ||
| Combined GA with epidural anesthesia | 0.838 | 0.459 | ||||
| Yes | 33 (11.1%) | 263 (88.9%) | 1 (7.1%) | 13 (92.9 %) | ||
| No | 28 (11.7%) | 211 (88.3%) | 23 (4.2%) | 528 (95.8%) | ||
| Maximal numerical pain score in 72 h | 6.0 ± 3.2 | 5.4 ± 3.2 | 0.205 | 5.8 ± 3.2 | 5.1 ± 3.2 | 0.331 |
| ARISCAT scores | 0.003 | < 0.001 | ||||
| < 26 | 4 (4.3%) | 89 (95.7%) | 3 (1.1%) | 282 (98.9%) | ||
| 26–44 | 29 (10.2%) | 256 (89.8%) | 12 (5.3%) | 216 (94.7%) | ||
| ≥ 45 | 28 (17.8%) | 129 (82.2%) | 9 (17.3%) | 43 (82.7%) | ||
| Total crystalloid received (mL) | 2200 (1300, 3875) | 1750 (1100, 2600) | 0.009 | 950 (525, 1300) | 450 (300, 650) | < 0.001 |
| Estimated blood loss (mL) | 500 (200, 1300) | 300 (100, 600) | < 0.001 | 150 (40, 275) | 10 (5, 30) | < 0.001 |
Data presented as mean ± SD, median (IQR)
Abbreviation: ARISCAT Assess Respiratory Risk in Surgical Patients in Catalonia